Efficacy of Invitro Expanded Bone Marrow Derived Allogeneic Mesenchymal Stem Cell Transplantation Via Portal Vein or Hepatic Artery or Peripheral Vein in Patients With Wilson Cirrhosis
Status:
This study is currently recruiting participants.
First Received:
June 20, 2011
Information provided by:
Gulhane Military Medical Academy
Sponsors and Collaborators:
Gulhane Military Medical Academy
Tubitak
Contacts:
Murat KANTARCIOGLU, MD ☎ +90 532 5607207 ➔ kantarci@hotmail.com
Safety and Efficacy of Umbilical Cord Mesenchymal Stem Cell Therapy for Patients With Progressive Multiple Sclerosis and Neuromyelitis Optica
Status:
Recruiting
First Received:
May 31, 2011
Information provided by:
Shenzhen Beike Bio-Technology Co., Ltd.
Sponsors and Collaborators:
- Shenzhen Beike Bio-Technology Co., Ltd.
- The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School
- The Affiliated Nanjing Brain Hospital of Nanjing University Medical School
- Nanjing University Medical College
- Affiliated Wuxi Second Hospital
Affiliated Hospital of Xuzhou Medical College
- The Second Hospital of Nanjing Medical University
Contacts:
Yun Yun Xu ➔ Xuyun20042001@yahoo.com.cn
Mesenchymal Stem Cells in the Treatment of Relapsed/Refractory Severe Acquired Aplastic Anemia
Status:
Recruiting
First Received:
February 16, 2011
Information provided by:
University of Sao Paulo
Sponsors and Collaborators:
University of Sao Paulo
Contacts:
Diego V Clé, MD ☎ 55-16-81126986 ➔ diegocle@yahoo.com
Rodrigo T Calado, MD ☎
55-16-36022610 ➔ rtcalado@fmrp.usp.br
Autologous Mesenchymal Stem Cells From Adipose Tissue in Patients With Secondary Progressive Multiple Sclerosis (CMM/EM/2008)
Status:
Recruiting
First Received:
January 25, 2010
Information provided by:
Fundacion Progreso y Salud, Spain
Sponsors and Collaborators:
Fundacion Progreso y Salud, Spain
Contacts:
Ana – Cardesa ☎ +34 95 501 90 40
Mesenchymal Stem Cells for the Treatment of MS
Status:
Active, not recruiting
First Received:
October 28, 2008
Information provided by:
Hadassah Medical Organization
Sponsors and Collaborators:
Hadassah Medical Organization
Contacts:
/
Mesenchymal Stem Cell Transplantation in MS (CMM-EM)
Status:
Not yet recruiting
First Received:
October 25, 2010
Information provided by:
Hospital Clinic of Barcelona
Sponsors and Collaborators:
Hospital Clinic of Barcelona
Instituto de Salud Carlos III
Contacts:
Albert Saiz, MD ☎ 34932275414 ➔asaiz@clinic.ub.es
Mesenchymal Stem Cells in Multiple Sclerosis (MSCIMS)
Status:
Active, not recruiting
First Received:
November 1, 2006
Information provided by:
University of Cambridge
Sponsors and Collaborators:
University of Cambridge
Cambridge University Hospitals NHS Foundation Trust
Medical Research Council
Contacts:
/
Autologous Mesenchymal Stem Cell (MSC) Transplantation in MS
Status:
Not yet recruiting
First Received:
December 22, 2008
Information provided by:
The Cleveland Clinic
Sponsors and Collaborators:
The Cleveland Clinic
University Hospital Case Medical Center
Contacts:
/
Allogeneic Mesenchymal Stem Cells Transplantation for Primary Sjögren's Syndrome (pSS)
Status:
Recruiting
First Received:
August 4, 2009
Information provided by:
The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School
Sponsors and Collaborators:
The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School
